Traws Pharma (TRAW) Preferred Stock Liabilities (2024)
Traws Pharma (TRAW) has disclosed Preferred Stock Liabilities for 3 consecutive years, with $111.6 million as the latest value for Q2 2024.
- For Q2 2024, Preferred Stock Liabilities changed N/A year-over-year to $111.6 million; the TTM value through Jun 2024 reached $111.6 million, changed N/A, while the annual FY2012 figure was $201.3 million, 67.77% up from the prior year.
- Preferred Stock Liabilities hit $111.6 million in Q2 2024 for Traws Pharma, down from $203.4 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $111.6 million in Q2 2024 and bottomed at $111.6 million in Q2 2024.